Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 study evaluating anamorelin HCl for malignancy-associated weight loss and anorexia in adults with advanced non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating anamorelin hydrochloride for malignancy-associated weight loss and anorexia in adults with advanced non-small cell …
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study evaluating sitravatinib in combination with nivolumab versus docetaxel in advanced/metastatic non-squamous non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. [Phase 3]
Phase III trial update evaluating durvalumab after curative-intent therapy in stage II-III non-small cell lung cancer; results were posted i…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating durvalumab with tremelimumab, with or without radiation therapy, in metastatic colorectal cancer and metastatic non…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Phase I Study of the BBP-398 in Patients With Advance Solid Tumors [Phase 1]
Phase I study of BBP-398 in patients with advanced solid tumors, including advanced or metastatic non-small cell lung cancer, has been termi…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations [Phase 1]
Phase 1 trial evaluating BBP-398 in combination with Osimertinib for locally advanced or metastatic non-small cell lung cancer with EGFR mut…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Study of Poziotinib in Japanese Patients With NSCLC [Phase 1, Phase 2]
A Phase 1/2 trial of Poziotinib in Japanese patients with non-small cell lung cancer was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors [Phase 1]
Phase 1 safety study evaluating encorafenib in Chinese patients with advanced/metastatic BRAF V600E-mutant solid tumors, including melanoma …
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer [Phase 3]
Clinical trial update for a Phase 3 study of selpercatinib in RET fusion-positive non-small cell lung cancer; results have been posted and t…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants [Phase 1]
Phase 1 study evaluating how itraconazole and carbamazepine affect BAY2927088 blood levels in healthy participants; study completed.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer [Phase 2]
A Phase II trial investigating Almonertinib in combination with Lastet for EGFR-positive non-small cell lung cancer; the study is not yet re…
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Cadonilimab is being studied in Phase 1/2 trials for advanced non-small cell lung cancer. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating whether dexamethasone-induced senescence can re-sensitize non-small cell lung cancer to PD-1 inhibitors;…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial evaluating selinexor with docetaxel in non-small cell lung cancer was terminated, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC [Phase 1, Phase 2]
An early-stage trial is evaluating trametinib plus anlotinib with tislelizumab for KRAS-mutant non-small cell lung cancer; the Phase 1/2 stu…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations [Phase 1, Phase 2]
A study of TPX-0046, a RET/SRC inhibitor, in adults with advanced solid tumors including non-small cell lung cancer and medullary thyroid ca…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Trop2 CAR-NK therapy for relapsed/refractory non-small cell lung cancer, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation [Phase 1]
Phase 1 trial assessing Capmatinib plus Trametinib for metastatic non-small cell lung cancer with MET exon 14 skipping mutation; the study s…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating FLT3 ligand immunotherapy in combination with stereotactic radiotherapy for advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Modified Si Jun Zi Tang in perioperative treatment for non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) [Phase 2]
Phase 2 trial results for the combination of tepotinib and osimertinib in osimertinib-relapsed MET-amplified non-small cell lung cancer (INS…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update reports completion and posted results for ADXS-503 with or without pembrolizumab in metastatic non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and resistance mechanisms of an investigational product (IP) in non-small cell lung …